Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 3 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 16 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 16 |
NetGPI | no | yes: 0, no: 16 |
Related structures:
AlphaFold database: Q4QFU5
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 217 | 221 | PF00656 | 0.494 |
CLV_C14_Caspase3-7 | 289 | 293 | PF00656 | 0.579 |
CLV_NRD_NRD_1 | 20 | 22 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 206 | 208 | PF00675 | 0.479 |
CLV_NRD_NRD_1 | 285 | 287 | PF00675 | 0.813 |
CLV_PCSK_KEX2_1 | 20 | 22 | PF00082 | 0.478 |
CLV_PCSK_KEX2_1 | 301 | 303 | PF00082 | 0.606 |
CLV_PCSK_PC1ET2_1 | 301 | 303 | PF00082 | 0.590 |
CLV_PCSK_SKI1_1 | 116 | 120 | PF00082 | 0.510 |
CLV_PCSK_SKI1_1 | 166 | 170 | PF00082 | 0.573 |
CLV_PCSK_SKI1_1 | 20 | 24 | PF00082 | 0.478 |
DEG_APCC_DBOX_1 | 19 | 27 | PF00400 | 0.511 |
DOC_CYCLIN_yClb1_LxF_4 | 267 | 273 | PF00134 | 0.509 |
DOC_MAPK_gen_1 | 48 | 57 | PF00069 | 0.444 |
DOC_PP1_RVXF_1 | 258 | 264 | PF00149 | 0.543 |
DOC_PP1_RVXF_1 | 46 | 52 | PF00149 | 0.561 |
DOC_USP7_MATH_1 | 162 | 166 | PF00917 | 0.439 |
DOC_USP7_MATH_1 | 98 | 102 | PF00917 | 0.571 |
LIG_14-3-3_CanoR_1 | 260 | 270 | PF00244 | 0.569 |
LIG_14-3-3_CanoR_1 | 90 | 98 | PF00244 | 0.476 |
LIG_BRCT_BRCA1_1 | 164 | 168 | PF00533 | 0.419 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.496 |
LIG_FHA_1 | 147 | 153 | PF00498 | 0.278 |
LIG_FHA_1 | 197 | 203 | PF00498 | 0.562 |
LIG_FHA_1 | 237 | 243 | PF00498 | 0.462 |
LIG_LIR_Apic_2 | 147 | 153 | PF02991 | 0.437 |
LIG_LIR_Apic_2 | 93 | 98 | PF02991 | 0.380 |
LIG_LIR_Gen_1 | 199 | 205 | PF02991 | 0.481 |
LIG_LIR_Gen_1 | 27 | 36 | PF02991 | 0.500 |
LIG_LIR_Gen_1 | 271 | 279 | PF02991 | 0.637 |
LIG_LIR_Gen_1 | 303 | 310 | PF02991 | 0.554 |
LIG_LIR_Gen_1 | 44 | 53 | PF02991 | 0.516 |
LIG_LIR_LC3C_4 | 133 | 138 | PF02991 | 0.490 |
LIG_LIR_Nem_3 | 199 | 203 | PF02991 | 0.420 |
LIG_LIR_Nem_3 | 27 | 32 | PF02991 | 0.502 |
LIG_LIR_Nem_3 | 44 | 49 | PF02991 | 0.465 |
LIG_PCNA_yPIPBox_3 | 191 | 201 | PF02747 | 0.352 |
LIG_PCNA_yPIPBox_3 | 228 | 242 | PF02747 | 0.410 |
LIG_SH2_CRK | 69 | 73 | PF00017 | 0.501 |
LIG_SH2_NCK_1 | 95 | 99 | PF00017 | 0.400 |
LIG_SH2_SRC | 95 | 98 | PF00017 | 0.351 |
LIG_SH2_STAP1 | 77 | 81 | PF00017 | 0.415 |
LIG_SH2_STAT5 | 200 | 203 | PF00017 | 0.500 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 80 | 83 | PF00017 | 0.390 |
LIG_SH3_1 | 69 | 75 | PF00018 | 0.513 |
LIG_SH3_3 | 69 | 75 | PF00018 | 0.494 |
LIG_SUMO_SIM_anti_2 | 215 | 222 | PF11976 | 0.491 |
MOD_CK1_1 | 144 | 150 | PF00069 | 0.521 |
MOD_CK1_1 | 236 | 242 | PF00069 | 0.630 |
MOD_CK1_1 | 253 | 259 | PF00069 | 0.353 |
MOD_CK2_1 | 242 | 248 | PF00069 | 0.587 |
MOD_CK2_1 | 81 | 87 | PF00069 | 0.513 |
MOD_Cter_Amidation | 18 | 21 | PF01082 | 0.519 |
MOD_GlcNHglycan | 16 | 20 | PF01048 | 0.580 |
MOD_GlcNHglycan | 220 | 224 | PF01048 | 0.562 |
MOD_GlcNHglycan | 234 | 238 | PF01048 | 0.575 |
MOD_GlcNHglycan | 252 | 255 | PF01048 | 0.576 |
MOD_GlcNHglycan | 265 | 268 | PF01048 | 0.544 |
MOD_GlcNHglycan | 276 | 279 | PF01048 | 0.610 |
MOD_GlcNHglycan | 280 | 283 | PF01048 | 0.636 |
MOD_GlcNHglycan | 59 | 62 | PF01048 | 0.414 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.478 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.630 |
MOD_GSK3_1 | 37 | 44 | PF00069 | 0.440 |
MOD_GSK3_1 | 53 | 60 | PF00069 | 0.382 |
MOD_GSK3_1 | 75 | 82 | PF00069 | 0.483 |
MOD_GSK3_1 | 8 | 15 | PF00069 | 0.550 |
MOD_N-GLC_1 | 261 | 266 | PF02516 | 0.450 |
MOD_N-GLC_1 | 27 | 32 | PF02516 | 0.442 |
MOD_N-GLC_1 | 41 | 46 | PF02516 | 0.497 |
MOD_N-GLC_2 | 108 | 110 | PF02516 | 0.450 |
MOD_N-GLC_2 | 159 | 161 | PF02516 | 0.482 |
MOD_NEK2_1 | 218 | 223 | PF00069 | 0.571 |
MOD_NEK2_1 | 263 | 268 | PF00069 | 0.629 |
MOD_NEK2_1 | 53 | 58 | PF00069 | 0.443 |
MOD_NEK2_1 | 81 | 86 | PF00069 | 0.492 |
MOD_PIKK_1 | 27 | 33 | PF00454 | 0.610 |
MOD_PKA_1 | 286 | 292 | PF00069 | 0.769 |
MOD_Plk_1 | 132 | 138 | PF00069 | 0.420 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.386 |
MOD_Plk_1 | 233 | 239 | PF00069 | 0.665 |
MOD_Plk_1 | 242 | 248 | PF00069 | 0.497 |
MOD_Plk_1 | 27 | 33 | PF00069 | 0.486 |
MOD_Plk_1 | 34 | 40 | PF00069 | 0.487 |
MOD_Plk_1 | 41 | 47 | PF00069 | 0.501 |
MOD_Plk_2-3 | 292 | 298 | PF00069 | 0.762 |
MOD_Plk_4 | 132 | 138 | PF00069 | 0.461 |
MOD_Plk_4 | 196 | 202 | PF00069 | 0.526 |
MOD_Plk_4 | 253 | 259 | PF00069 | 0.538 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.431 |
MOD_SUMO_rev_2 | 111 | 118 | PF00179 | 0.511 |
MOD_SUMO_rev_2 | 121 | 126 | PF00179 | 0.486 |
MOD_SUMO_rev_2 | 281 | 289 | PF00179 | 0.692 |
TRG_DiLeu_BaEn_1 | 121 | 126 | PF01217 | 0.593 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.518 |
TRG_ENDOCYTIC_2 | 226 | 229 | PF00928 | 0.609 |
TRG_ENDOCYTIC_2 | 305 | 308 | PF00928 | 0.546 |
TRG_ER_diArg_1 | 20 | 22 | PF00400 | 0.503 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I0V1 | Leptomonas seymouri | 57% | 100% |
A0A0S4KDQ4 | Bodo saltans | 43% | 100% |
A0A1X0NQ77 | Trypanosomatidae | 44% | 99% |
A0A381MFS8 | Leishmania infantum | 76% | 100% |
A0A3Q8I9T1 | Leishmania donovani | 86% | 100% |
A0A3R7N2S2 | Trypanosoma rangeli | 44% | 97% |
A0A3S7WSX7 | Leishmania donovani | 75% | 100% |
A4H7J8 | Leishmania braziliensis | 50% | 100% |
C9ZT43 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 41% | 94% |
E9AGK8 | Leishmania infantum | 83% | 100% |
E9APN2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 72% | 100% |
E9APN3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 77% | 100% |
E9APN4 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 71% | 100% |
Q4QFU6 | Leishmania major | 91% | 100% |
V5BD72 | Trypanosoma cruzi | 43% | 97% |